Prevalence of thyroid dysfunction during first trimester of pregnancy: A descriptive cross‐sectional study

Sandip. K. Sharma, Geeta Gurung, N. Katuwal, P. Joshi, Hemu Chaurasia, Sunita Lamsal
{"title":"Prevalence of thyroid dysfunction during first trimester of pregnancy: A descriptive cross‐sectional study","authors":"Sandip. K. Sharma, Geeta Gurung, N. Katuwal, P. Joshi, Hemu Chaurasia, Sunita Lamsal","doi":"10.1002/rfc2.53","DOIUrl":null,"url":null,"abstract":"Thyroid dysfunction carries large burden during pregnancy and untreated thyroid dysfunction is associated with poor maternal and foetal outcome. The exact burden of thyroid dysfunction during pregnancy in Nepal is not well established. This is descriptive cross‐sectional study done in tertiary care centre of Nepal to know burden of thyroid dysfunction and establish possible need of universal thyroid function screening during pregnancy.A descriptive cross‐sectional study was conducted from 4 September 2020 to 3 September 2021 on pregnant women attending to ANC clinic during their first trimester after obtaining ethical approval. Among eligible patients, after taking informed consent, a total of 385 pregnant women were included in the study. Thyroid function status was assessed by measuring serum levels of thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri‐iodothyronine (FT3). Women with pre‐existing thyroid disorders were excluded. Serum thyroid function was used to detect thyroid disorder based on American Thyroid Association 2011 criteria. A convenience sampling method was used. Point estimate and 95% confidence interval (CI) were calculated.Among 385 pregnant women, 152 (39.48%) (39.20–39.70, 95% CI) had thyroid disorders. Among thyroid disorders (n = 152), 111 (28.83%) had subclinical hypothyroidism, 37 (9.61%) overt hypothyroidism, 3 (0.78%) subclinical hyperthyroidism and 1 (0.26%) had overt hyperthyroidism.Around four in every 10 pregnant women had thyroid disorder. Thyroid dysfunction is easily detectable and can be effectively, inexpensively treated, which can prevent adverse maternal and foetal outcome. Thus, we should consider universal screening of pregnant women for thyroid disorder especially in a country like Nepal where there is a high prevalence of undiagnosed thyroid disorder.","PeriodicalId":74669,"journal":{"name":"Reproductive, female and child health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive, female and child health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/rfc2.53","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Thyroid dysfunction carries large burden during pregnancy and untreated thyroid dysfunction is associated with poor maternal and foetal outcome. The exact burden of thyroid dysfunction during pregnancy in Nepal is not well established. This is descriptive cross‐sectional study done in tertiary care centre of Nepal to know burden of thyroid dysfunction and establish possible need of universal thyroid function screening during pregnancy.A descriptive cross‐sectional study was conducted from 4 September 2020 to 3 September 2021 on pregnant women attending to ANC clinic during their first trimester after obtaining ethical approval. Among eligible patients, after taking informed consent, a total of 385 pregnant women were included in the study. Thyroid function status was assessed by measuring serum levels of thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri‐iodothyronine (FT3). Women with pre‐existing thyroid disorders were excluded. Serum thyroid function was used to detect thyroid disorder based on American Thyroid Association 2011 criteria. A convenience sampling method was used. Point estimate and 95% confidence interval (CI) were calculated.Among 385 pregnant women, 152 (39.48%) (39.20–39.70, 95% CI) had thyroid disorders. Among thyroid disorders (n = 152), 111 (28.83%) had subclinical hypothyroidism, 37 (9.61%) overt hypothyroidism, 3 (0.78%) subclinical hyperthyroidism and 1 (0.26%) had overt hyperthyroidism.Around four in every 10 pregnant women had thyroid disorder. Thyroid dysfunction is easily detectable and can be effectively, inexpensively treated, which can prevent adverse maternal and foetal outcome. Thus, we should consider universal screening of pregnant women for thyroid disorder especially in a country like Nepal where there is a high prevalence of undiagnosed thyroid disorder.
妊娠早期甲状腺功能障碍的患病率:一项描述性横断面研究
甲状腺功能障碍在妊娠期间负担很大,未经治疗的甲状腺功能障碍与不良的母婴结局有关。在尼泊尔,怀孕期间甲状腺功能障碍的确切负担尚未得到很好的确定。这是在尼泊尔三级保健中心进行的描述性横断面研究,以了解甲状腺功能障碍的负担,并确定怀孕期间普遍进行甲状腺功能筛查的可能必要性。一项描述性横断面研究于2020年9月4日至2021年9月3日对获得伦理批准后孕早期到ANC诊所就诊的孕妇进行。在符合条件的患者中,在知情同意后,共有385名孕妇被纳入研究。通过测定血清促甲状腺激素(TSH)、游离甲状腺素(FT4)和游离三碘甲状腺原氨酸(FT3)水平来评估甲状腺功能状态。排除了既往存在甲状腺疾病的女性。根据美国甲状腺协会2011年标准,采用血清甲状腺功能检测甲状腺疾病。采用方便抽样方法。计算点估计和95%置信区间(CI)。在385名孕妇中,152名(39.48%)(39.20-39.70,95% CI)患有甲状腺疾病。152例甲状腺疾病中,亚临床甲状腺功能减退111例(28.83%),显性甲状腺功能减退37例(9.61%),亚临床甲状腺功能亢进3例(0.78%),显性甲状腺功能亢进1例(0.26%)。大约每10个孕妇中就有4个患有甲状腺疾病。甲状腺功能障碍很容易检测到,并且可以有效、廉价地治疗,这可以预防不良的母婴结局。因此,我们应该考虑对孕妇进行甲状腺疾病的普遍筛查,特别是在尼泊尔这样一个未确诊甲状腺疾病患病率很高的国家。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信